ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
SPDR S&P Biotech ETF
156.20
-0.6200
-0.40%
盤後:
156.43
0.2300
+0.15%
19:59 EDT
成交量:
841.39萬
成交額:
13.25億
市值:
105.24億
市盈率:
8.57
高:
159.66
開:
158.27
低:
156.13
收:
156.82
52周最高:
169.89
52周最低:
92.64
股本:
6,737.50萬
流通股本:
6,737.50萬
量比:
1.28
換手率:
12.49%
股息:
0.56
股息率:
0.36%
每股收益(TTM):
18.23
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞
公告
貫徹實施民營經濟促進法典型案例(第二批)
市场资讯
·
09/01
【「十五五」開局看趙縣——生物醫藥篇】創新驅動增動能 科技賦能產業升級
赵州发布
·
09/01
北京成立生物醫藥等三個共保體 支持科技創新
智通财经
·
09/01
百濟神州:PD-1抗癌藥降價加入美國公共醫療保險計劃 今後上市創新藥均將執行最惠國定價
每日经济新闻
·
09/01
生物醫藥邁向「源頭創新」
证券日报
·
09/01
北京:聚焦集成電路、生物醫藥、航空航天、高端裝備等優勢產業,鞏固對外貿易傳統市場
智通财经
·
08/31
【新股IPO】維眸生物科技向港交所主板提交上市申請
金吾财讯
·
08/31
9月1日起,烏魯木齊靈活就業人員可參加生育保險 !
新疆949交通广播
·
08/30
Electra Therapeutics(ETRA.US)遞交美股IPO申請,借生物科技上市熱潮推進免疫疾病與癌症新藥研發
智通财经
·
08/29
Electra Therapeutics(ETRA.US)遞交美股IPO申請,借生物科技上市熱潮推進免疫疾病與癌症新藥研發
智通财经
·
08/29
逾五成深市生物醫藥公司業績「報喜」 下半年增長勢頭有望延續
经济参考网
·
08/28
美股生物醫藥股盤初走低,BioNTech跌超9%、Moderna跌近5%
老虎资讯综合
·
08/28
英國風險投資強勁反彈 軟件與生物科技領跑融資
环球市场播报
·
08/28
港股早評:三大指數低開,科網股普跌,生物醫藥股明顯強勢
中金财经
·
08/28
行業傳利好 29只生物醫藥股滾動市盈率低於30倍
智通财经
·
08/28
加拿大皇家銀行首席執行官在電話會議上表示,市場環境總體上仍保持建設性態勢,自然資源、電力基礎設施、戰略防禦、醫療保健及人
智通财经
·
08/27
醫療健康板塊市場動態綜述
投资观察
·
08/27
人民健康保險銅川分公司被罰9.9萬,涉虛掛中介業務套取費用
蓝鲸财经
·
08/27
福建:擬支持海峽兩岸生物技術和醫療健康產業合作區建設
格隆汇APP
·
08/27
福建:擬支持海峽兩岸生物技術和醫療健康產業合作區建設
智通财经
·
08/27
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/XBI/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"SPDR S&P Biotech ETF","latestPrice":156.2,"timestamp":1789156800000,"preClose":156.82,"halted":0,"volume":8413893,"hourTrading":{"tag":"盘后","latestPrice":156.43,"preClose":156.2,"latestTime":"19:59 EDT","volume":555911,"amount":86836947.7522,"timestamp":1789171191129,"change":0.23,"changeRate":0.001472,"amplitude":0.001601},"delay":0,"changeRate":-0.0039535773498278574,"floatShares":67375000,"shares":67375000,"eps":18.23,"marketStatus":"休市中","change":-0.62,"latestTime":"09-11 16:00:00 EDT","open":158.27,"high":159.6607,"low":156.13,"amount":1324607084.0494199,"amplitude":0.022514,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":156.82,"sharesOutstanding":63325000,"nav":156.174274,"aum":10736981366.38,"dividendRate":0.003615,"bidAskSpread":0.000302,"preHourTrading":{"tag":"盘前","latestPrice":158.23,"preClose":156.82,"latestTime":"09:29 EDT","volume":40501,"amount":6393566.4319400005,"timestamp":1789133399999,"change":1.41,"changeRate":0.008991,"amplitude":0.013009},"postHourTrading":{"tag":"盘后","latestPrice":156.43,"preClose":156.2,"latestTime":"19:59 EDT","volume":555911,"amount":86836947.7522,"timestamp":1789171191129,"change":0.23,"changeRate":0.001472,"amplitude":0.001601},"volumeRatio":1.2777409531718278,"optionData":{"bulkOrders":[{"symbol":"XBI","call":false,"expireDate":1790308800000,"strike":"157.0","timestamp":1789148514638,"price":3.65,"volume":2865,"amount":1045725,"type":"+"},{"symbol":"XBI","call":false,"expireDate":1790308800000,"strike":"150.0","timestamp":1789148514638,"price":1.15,"volume":2865,"amount":329475,"type":"-"}]},"impliedVol":0.2874,"impliedVolPercentile":0.1554},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":67375000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.2777409531718278,"shares":67375000,"dividePrice":0.5646,"high":159.6607,"amplitude":0.022514,"preClose":156.82,"low":156.13,"week52Low":92.64,"pbRate":"--","week52High":169.89,"institutionHeld":0.8511,"latestPrice":156.2,"eps":18.23,"divideRate":0.003615,"volume":8413893,"delay":0,"ttmEps":18.23,"open":158.27,"prevYearClose":121.93,"prevWeekClose":163.81,"prevMonthClose":162.5,"prevQuarterClose":158.25,"fiveDayClose":164.38,"twentyDayClose":156.86,"sixtyDayClose":135.34},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664857540","title":"貫徹實施民營經濟促進法典型案例(第二批)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664857540","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664857540?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 22:12","pubTimestamp":1788271920,"startTime":"0","endTime":"0","summary":"在《中华人民共和国民营经济促进法》实施一周年之际,国家发展改革委、最高人民法院联合发布贯彻实施民营经济促进法典型案例(第二批),聚焦民企纾困、权益保护、公平营商、涉外解纷四大核心领域,以鲜活裁判打通法条落地“最后一公里”。该案成功办理充分体现了《中华人民共和国民营经济促进法》第二十七条、第三十三条、第七十四条规定精神,检察机关通过加大对创新成果的知识产权保护力度,为企业自主创新提供有力保障。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-09-01/doc-iniqixxq1485773.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","BK4585","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664276851","title":"【「十五五」開局看趙縣——生物醫藥篇】創新驅動增動能 科技賦能產業升級","url":"https://stock-news.laohu8.com/highlight/detail?id=2664276851","media":"赵州发布","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664276851?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 20:38","pubTimestamp":1788266280,"startTime":"0","endTime":"0","summary":"“十五五”开局之年,赵县锚定百亿级生物医药产业集群建设目标,引导生物医药企业把科技创新摆在发展突出位置,持续建强科研载体、深化产学研协同,积极探索新型研发合作模式,以技术攻关激活产业内生新动能。立足“十五五”开局,赵县持续引导生物医药企业强化科研攻关,厚植创新沃土,不断激活产业内生动力,全力向着百亿级生物医药产业集群建设目标稳步迈进。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-09-01/doc-iniqitru8318929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4581","XBI","BK4588","161726","BK4585","399441"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664985878","title":"北京成立生物醫藥等三個共保體 支持科技創新","url":"https://stock-news.laohu8.com/highlight/detail?id=2664985878","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664985878?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 18:33","pubTimestamp":1788258782,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","XBI","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664026884","title":"百濟神州:PD-1抗癌藥降價加入美國公共醫療保險計劃 今後上市創新藥均將執行最惠國定價","url":"https://stock-news.laohu8.com/highlight/detail?id=2664026884","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664026884?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 09:36","pubTimestamp":1788226577,"startTime":"0","endTime":"0","summary":"美国当地时间8月31日,美国总统特朗普宣布与9家制药企业达成全新协议,为美国民众下调处方药价格,药价对标其他发达国家的最低采购价,即“最惠国(MFN)价格”,其中包括国内创新药龙头百济神州。9月1日,百济神州对《每日经济新闻》记者表示,根据协议,百济神州将通过Medicaid项目,以约定的价格向符合条件的患者提供替雷利珠单抗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609013861069086.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609013861069086.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06978","KURE","LU0228659784.USD","MEDX","159992","688235","BK1583","BK4581","BK4023","XLV","BK1500","BK4585","LU1251922891.USD","LU0828237510.HKD","LU1303224171.USD","LU1770034418.SGD","BK4588","XBI","BK1588","LABU","06160","BK1161","BK1574","ONC","LU1969619763.USD","LU0588546209.SGD","IBBQ","LU2328871848.SGD","PD","LU1169589451.USD","IPOS","BK0239","CANC","LNGR","BK4139","LU1169590202.USD","BK4526","LU0307460666.USD","LU1719994722.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664074520","title":"生物醫藥邁向「源頭創新」","url":"https://stock-news.laohu8.com/highlight/detail?id=2664074520","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664074520?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 00:45","pubTimestamp":1788194700,"startTime":"0","endTime":"0","summary":"截至8月31日,A股、港股生物医药上市公司2026年半年报已全部披露完毕。从披露的经营数据来看,今年上半年,生物医药行业业绩分化进一步加剧,传统药企承压转型,创新药企盈利拐点显现。其中,头部药企研发投入稳步攀升、创新动能不断积聚,叠加国际化提速、AI制药应用加快,展现出中国生物医药正迎来从“跟随创新”向“源头创新”的关键转折。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609013860522190.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609013860522190.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["399441","XBI","BK4588","BK4585","BK4581","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663407606","title":"北京:聚焦集成電路、生物醫藥、航空航天、高端裝備等優勢產業,鞏固對外貿易傳統市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2663407606","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663407606?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 17:26","pubTimestamp":1788168364,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4581","PPA","BK4588","UFO","XAR","XBI","BK4585","DFEN","BK4564"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663023248","title":"【新股IPO】維眸生物科技向港交所主板提交上市申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2663023248","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663023248?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 09:06","pubTimestamp":1788138403,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据港交所8月28日披露,维眸生物科技向港交所主板提交上市申请,中金公司为独家保荐人。公司成立于2016年,是一家聚焦眼科领域的临床阶段生物科技企业。公司拥有两款核心产品VVN461(高剂量)及VVN001。公司拟将集资所得用于核心产品VVN461(高剂量)的开发;VVN001的临床开发及注册;其他候选产品的开发及注册;组建内部商业化团队及营销活动;及营运资金及其他一般企业用途。","market":"fut","thumbnail":"https://static.szfiu.com/news/20220324/MmFjZGExNjQxMjAyMjczMTQ1Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20220324/MmFjZGExNjQxMjAyMjczMTQ1Mg==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1989968","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XBI","HEXmain","KCE","AGNG","BK4585","IEIH","BK4588","IBBJ","HBImain","GDOC","SYNB","LNGR","159837","MEDX","IPOS","FRHC","BK4127","REDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663462770","title":"9月1日起,烏魯木齊靈活就業人員可參加生育保險 !","url":"https://stock-news.laohu8.com/highlight/detail?id=2663462770","media":"新疆949交通广播","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663462770?lang=zh_tw&edition=fundamental","pubTime":"2026-08-30 15:09","pubTimestamp":1788073740,"startTime":"0","endTime":"0","summary":"灵活就业人员完成生育保险参保登记后,按照税务部门征管规定按月申报缴纳生育保险费,缴费渠道、征管方式与职工基本医疗保险一致,由税务部门统一征收。待遇保障方面,灵活就业人员连续缴纳职工医保满6个月,即可享受生育医疗费用报销。生育津贴方面,参加生育保险的灵活就业人员生育相关手术发生时,生育保险连续缴费满10个月,可按月申领生育津贴;缴费不足10个月的,缴满10个月后再申领。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-08-30/doc-iniqaqpr2826938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XLV","BK4585","BK4581","BK4588","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663114360","title":"Electra Therapeutics(ETRA.US)遞交美股IPO申請,借生物科技上市熱潮推進免疫疾病與癌症新藥研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2663114360","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663114360?lang=zh_tw&edition=fundamental","pubTime":"2026-08-29 11:05","pubTimestamp":1787972713,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,生物科技公司Electra Therapeutics Inc.已正式递交首次公开募股申请,欲借今年生物科技板块IPO强劲表现的东风,为其处于临床阶段的免疫介导疾病和癌症药物管线筹集资金。截至今年6月30日,公司持有现金及现金等价物约9770万美元。其中,脱发治疗药物研发商Veradermics Inc.自2月上市以来股价飙升476%,领跑该板块。Electra此次IPO的主承销商包括杰富瑞金融集团、多伦多道明银行、Evercore Inc.和Cantor Fitzgerald。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488928.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","IPOS","BK4127","BK4139","159837","BK4581","KCE","GDOC","IEIH","FRHC","SYNB","MEDX","BK4588","LENZ","IBBJ","BK4007","HBImain","BK4539","LNGR","REDS","AGNG","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663011439","title":"Electra Therapeutics(ETRA.US)遞交美股IPO申請,借生物科技上市熱潮推進免疫疾病與癌症新藥研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2663011439","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663011439?lang=zh_tw&edition=fundamental","pubTime":"2026-08-29 11:05","pubTimestamp":1787972713,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","KCE","MEDX","XBI","LENZ","BK4139","BK4585","IPOS","REDS","FRHC","SYNB","GDOC","BK4539","BK4588","IEIH","AGNG","BK4581","BK4127","IBBJ","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662092342","title":"逾五成深市生物醫藥公司業績「報喜」 下半年增長勢頭有望延續","url":"https://stock-news.laohu8.com/highlight/detail?id=2662092342","media":"经济参考网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662092342?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 22:27","pubTimestamp":1787927220,"startTime":"0","endTime":"0","summary":"截至8月27日,深市生物医药板块已有213家上市公司披露2026年半年度报告,其中超过五成公司实现业绩增长,34家业绩同比增幅超过100%,11家增幅在50%至100%之间,另有16家公司成功扭亏为盈。报告期内,公司创新药国内销售保持快速增长,同时完成多项产品对外授权合作并按协议取得部分首付款,带来大额授权收入。综合来看,深市生物医药行业2026年上半年呈现创新驱动、结构优化、盈利改善的积极态势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-28/doc-inipwtfm4404159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["399441","XBI","BK4588","BK4585","BK4581","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100460280","title":"美股生物醫藥股盤初走低,BioNTech跌超9%、Moderna跌近5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1100460280","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100460280?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 21:37","pubTimestamp":1787924271,"startTime":"0","endTime":"0","summary":"8月28日,美股生物医药股盘初走低,$BioNTech(BNTX)$跌超9%,公司宣布终止结直肠癌2期临床试验;$Moderna(MRNA)$跌近5%,$默沙东(MRK)$跌1.5%。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHE","LU0058720904.USD","LU1066051225.USD","LU0985320562.USD","XLV","LU0868494708.USD","LU1989772923.USD","LU1917777945.USD","LU1989772840.SGD","LU2125909247.SGD","LU0320765489.SGD","IE00BBT3K403.USD","PAWZ","BK4551","BMED","LU1934455194.USD","IE00BLSP4452.SGD","LU1291159041.SGD","BK4548","SG9999014542.SGD","SG9999013999.USD","WDNA","IE00BFTCPJ56.SGD","LU1430594728.SGD","RXL","BK4534","LU0265550946.USD","XBI","LU1037948541.HKD","LU1941712264.USD","LU2361044949.HKD","LU1116320737.USD","IXJ","MRNX","LU1699723380.USD","BK4516","LU2468319806.SGD","LU1201861249.SGD","IE00B1BXHZ80.USD","LU0859254822.USD","LU0689626769.HKD","LU1066051811.HKD","LU2433249047.HKD","TRUH","LU1066051498.USD","LU0238689110.USD","GNOM","BK4550","IE0002141913.USD","IE00BJT1NW94.SGD","LU0289739699.SGD","LU2089984988.USD","IBBQ","LU1037948897.HKD","MRNA","LU0070302665.USD","SG9999001176.USD","LU0823416689.USD","VHT","LGHT","LU1057294990.SGD","LU1061106388.HKD","LU0432979614.USD","SG9999002232.USD","GDOC","LU2106854487.HKD","SG9999014559.SGD","LU0477156953.USD","LU1934455277.USD","LU2112291526.USD","LU1035773651.USD","LU1974910355.USD","LU0106261372.USD","IE0009355771.USD","LU0965509283.SGD","LU0861579265.USD","MRK","LU2360032135.SGD","LU1941712348.USD","LU0868494617.USD","JDOC","161726","BK4581","BK4532","BK4139","LU2023250504.SGD","BK4533","LU2125909593.SGD","LU2361045086.USD","IBBJ","LU2324357040.USD","LU0234572021.USD","LU2125154778.USD","IE00BLSP4239.USD","LU2461242641.AUD","SG9999001176.SGD","LU0124676726.USD","LU0203345920.USD","LU0211331839.USD","LU1989771016.USD","LU0130517989.USD","LU1571399168.USD","SG9999014575.USD","SG9999001440.SGD","PSYK","LU1069347547.HKD","LU1116320901.HKD","LU0980610538.SGD","LU2361044865.SGD","LU0942090050.USD","LU0122379950.USD","LU0965509010.AUD","HRTS","BK4585","BNTX","LU0130102774.USD","IE00B4R5TH58.HKD","LU2491050154.USD","SG9999014567.USD","LU1923622614.USD","SG9999015358.SGD","BK4007","LU2023250843.SGD","FHLC","LU1093756168.USD","LU2357627491.SGD","LU0320765646.SGD","LU1066053197.SGD","LU0965509101.SGD","LU1929549753.HKD","LU0203347892.USD","MRNY","LU0208291251.USD","FTXH","IE00BSNM7G36.USD","PPH","BK4588","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","SGXZ57979304.SGD","LU0265550359.USD","LU0098860793.USD","BK4559","IDNA","IE00BN8TJ469.HKD","LU1934455863.HKD","SG9999015341.SGD","IE000M9KFDE8.USD","LU2491050071.SGD","BK4501","BK4568","LU1023059063.AUD","LU2491049909.HKD","LU1585245621.USD","LU1093756325.SGD","LU0965508806.USD","LU1162221912.USD","LU0266013472.USD","LU2125154935.USD","LU1983299246.USD","MDTX","SG9999002224.SGD","IYH","LU0648001328.SGD","LU0006306889.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662065286","title":"英國風險投資強勁反彈 軟件與生物科技領跑融資","url":"https://stock-news.laohu8.com/highlight/detail?id=2662065286","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662065286?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 17:36","pubTimestamp":1787909760,"startTime":"0","endTime":"0","summary":"2026年上半年,英国风险投资总额达144亿英镑,全年有望突破2021年创下的260亿英镑纪录,创历史新高。PitchBook数据显示,今年英国风投中,英国本土投资者仅占融资总额的11%,为历史较低水平,美国买家历来占据主导地位。与此同时,英国富裕零售投资者对旨在激励早期企业融资的风投信托基金兴趣减弱。在具体交易方面,AI与生命科学公司Isomorphic Labs及自动驾驶技术集团Wayve成为今年融资主力,第二季度分别完成15亿和9.45亿英镑融资。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-28/doc-inipwhrt5802738.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["VGT","AGNG","IBBJ","159837","MEDX","HBImain","BK4588","SYNB","IEIH","BK4585","BK4581","LNGR","GDOC","XBI","159180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662403038","title":"港股早評:三大指數低開,科網股普跌,生物醫藥股明顯強勢","url":"https://stock-news.laohu8.com/highlight/detail?id=2662403038","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662403038?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 09:37","pubTimestamp":1787881021,"startTime":"0","endTime":"0","summary":"受英伟达强劲业绩指引提振,隔夜美股三大指数集体收涨。港股三大指数低开,恒指跌0.61%,国指跌0.76%,恒生科技指数跌0.85%。大型科网股普遍下跌,阿里巴巴跌,美团、京东、百度跌超1%,腾讯跌0.85%;英伟达绩后昨日就抢跑的存储半导体股、光通信概念股、PCB概念股表现平淡,生物医药股明显强势,同源康医药大幅高开约15%。另外,海运股、濠赌股、家电股普遍走低。(格隆汇)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260828/32351159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK4581","KCAI","BK4585","161726","399441","VXUS","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662034994","title":"行業傳利好 29只生物醫藥股滾動市盈率低於30倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2662034994","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662034994?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 08:17","pubTimestamp":1787876228,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBI","BK4585","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662470717","title":"加拿大皇家銀行首席執行官在電話會議上表示,市場環境總體上仍保持建設性態勢,自然資源、電力基礎設施、戰略防禦、醫療保健及人","url":"https://stock-news.laohu8.com/highlight/detail?id=2662470717","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662470717?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 20:37","pubTimestamp":1787834238,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["VHT","CSIO","BK4130","TRFM","VOLT","TCAI","BK4588","CSEN","JOUL","NOBL","XBI","MGNR","BK4550","BK4596","PWRD","BILT","TEXN","LABU","BLDX","NFRA","TPZ","RIFR","CGVV","BK4585","IPAV","NFRX","XLV","XPAV","FAN","KWH","BILD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197781007","title":"醫療健康板塊市場動態綜述","url":"https://stock-news.laohu8.com/highlight/detail?id=1197781007","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197781007?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 16:25","pubTimestamp":1787819101,"startTime":"0","endTime":"0","summary":"此外,诺和诺德的ziltivekimab药物在一项晚期临床试验中未能降低心脏病发作或中风风险后,实际上已退出竞争舞台。这家丹麦制药巨头下月将迎来一场至关重要的资本市场日活动,德意志银行补充道。消息公布后,公司股价下滑1.6%,报300.10丹麦克朗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001127.SGD","LU0235996351.USD","LU0672654166.SGD","LU0675040207.SGD","LU0955648018.USD","LU1839390173.USD","LU0878004406.USD","SG9999001226.SGD","LU0205439572.USD","XLV","SG9999001903.USD","SG9999011175.SGD","SG9999000343.SGD","LU0823417737.USD","SG9999005177.SGD","LU0441854154.USD","SG9999016042.SGD","LU2506952097.USD","LU0588545904.SGD","SG9999002604.SGD","SG9999013486.USD","LU1956131251.USD","LU0326948709.USD","IE00BVYPNP33.GBP","LU2238330802.EUR","LU0823397103.USD","LU2506951875.HKD","SG9999002620.SGD","SG9999014484.SGD","IE0003895053.USD","SG9999003800.SGD","LU1497733557.USD","SG9999013353.USD","LU0557290698.USD","LU2152927971.USD","LU2506952170.USD","SG9999001135.SGD","XBI","IE00BGHQDM52.EUR","LU0210637038.USD","BK6112","LU0971096721.USD","LU0543330483.HKD","LU0823038988.USD","SG9999013478.USD","LU1211504680.USD","LU0169518387.USD","LU0261945553.USD","SGXZ24219693.SGD","LU0648948544.HKD","LU0061477393.USD","SG9999002414.USD","SG9999014492.USD","SGXZ43160589.SGD","SGXZ16066938.SGD","LU0345776255.USD","LU0251143029.SGD","LU0823413660.USD","LU1363072403.SGD","LU0084288322.USD","LU0955623706.USD","LU0823397285.USD","LU0384037296.USD","LU1634259557.SGD","IE00BKZH1Z71.USD","LU0577902611.USD","LU0043850808.USD","LU2257852520.SGD","SG9999004360.SGD","SG9999006266.SGD","SG9999008742.SGD","SGXZ70427877.SGD","LU0165289439.USD","LU0188438112.USD","LU1634259391.SGD","SG9999002562.SGD","LU0577902371.SGD","SG9999013460.SGD","LU0488056044.USD","SG9999000459.SGD","BK4581","LU0577902454.USD","SG9999009443.AUD","BK6516","LU0011963245.USD","LU0762540952.USD","LU0441851309.USD","LU1497733631.SGD","LU0048597586.USD","SGXZ27511609.SGD","LU0831093199.SGD","LU2237957811.SGD","LU1282649067.USD","LU0950375773.USD","SG9999014302.SGD","LU0211331839.USD","LU0048573645.USD","LU0251144936.SGD","SG9999000475.SGD","LU1497734951.SGD","LU0873338254.USD","LU0831103253.SGD","LU0588545490.SGD","SG9999007991.SGD","SG9999002406.SGD","LU0532188223.SGD","LU1282649141.HKD","BK6523","LU2237957902.USD","LU0128522157.USD","BK4585","LU0345775950.USD","SG9999001846.SGD","LU1504937902.USD","SG9999002679.SGD","SGXZ91733576.SGD","LU0315178854.USD","IE00BVYPNQ40.USD","LU0882747503.HKD","LABU","BK4588","LU0823417653.USD","IE0031814969.USD","LU2506951958.HKD","SG9999003826.SGD","LU1770036033.HKD","LU0955669360.SGD","LU0096374516.USD","LU0630378429.USD","LU1130305938.SGD","LU0737861269.HKD","D05.SI","LU3227948356.SGD","LU0588545730.USD","SGXZ58947870.SGD","LU0577902298.EUR","LU1522347837.USD","LU0823039010.USD","LU1282649810.SGD","LU0823413587.USD","LU0865486749.SGD","LU0878005551.USD","SG9999003925.USD","LU0192582467.USD","LU0261947096.USD","LU0577902538.SGD","LU0320764755.SGD","LU0886674414.USD","LU0029875118.USD","SGXZ51708014.SGD","SG9999004220.SGD","LU0898667661.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662775745","title":"人民健康保險銅川分公司被罰9.9萬,涉虛掛中介業務套取費用","url":"https://stock-news.laohu8.com/highlight/detail?id=2662775745","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662775745?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:56","pubTimestamp":1787813815,"startTime":"0","endTime":"0","summary":"蓝鲸新闻8月27日讯,近日,铜川金融监管分局发布行政处罚决定书,剑指中国人民健康保险股份有限公司铜川分公司及相关责任人。罚单显示,中国人民健康保险股份有限公司铜川分公司的主要违法违规行为是:利用保险代理人虚挂中介业务套取费用。针对上述违法行为,铜川金融监管分局对中国人民健康保险股份有限公司铜川分公司罚款9.9万元;对宋鹏飞给予警告并处罚款1.1万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787810487255386596","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["XBI","BK4585","BK4581","XLV","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662775292","title":"福建:擬支持海峽兩岸生物技術和醫療健康產業合作區建設","url":"https://stock-news.laohu8.com/highlight/detail?id=2662775292","media":"格隆汇APP","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662775292?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:49","pubTimestamp":1787813340,"startTime":"0","endTime":"0","summary":"格隆汇8月27日丨今日,《福建省“十五五”卫生健康发展规划》印发。其中提到,深化卫生健康两岸融合发展,构建跨区域开放发展新格局。加强两岸医疗健康产业合作,推动闽台在生物医药研发、重大疾病防控、前沿医疗技术研究等领域交流合作。支持海峡两岸生物技术和医疗健康产业合作区建设。深化闽台医药融合,鼓励引进台湾地区已上市的高临床价值创新药械在本省医疗机构应用。支持福建中医药大学建设闽台融合中医药重点实验室。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2026-08-27/doc-inipttav9117970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["VHT","LABU","WDNA","XBI","BK4585","159760","HELX","BK4550","IXJ","BK4581","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662077593","title":"福建:擬支持海峽兩岸生物技術和醫療健康產業合作區建設","url":"https://stock-news.laohu8.com/highlight/detail?id=2662077593","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662077593?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:45","pubTimestamp":1787813117,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBI","HELX","IXJ","BK4588","WDNA","BK4550","BK4581","VHT","XLV","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}